Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Senseonics NYSE:SENS$0.44 -0.01 (-1.51%) Closing price 04:00 PM EasternExtended Trading$0.44 +0.00 (+0.28%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about SenseonicsMarket Capitalization$355.04 millionP/E Ratio-3.35Consensus RatingBuyConsensus Price Target$1.54 (+252.8% Upside)Volume3.98 million sharesAverage Volume7.83 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. zSpace NASDAQ:ZSPC$0.98 -0.12 (-10.93%) As of 04:00 PM EasternzSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpaceMarket Capitalization$26.44 millionConsensus RatingBuyConsensus Price Target$10.00 (+920.6% Upside)Volume2.52 million sharesAverage Volume1.44 million sharesToday's Range$0.87▼$1.133. Western Copper & Gold NYSE:WRN$1.97 -0.01 (-0.51%) As of 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$397.26 millionP/E Ratio-98.50Consensus RatingBuyConsensus Price Target$4.25 (+115.7% Upside)Volume713,459 sharesAverage Volume410,135 shares4. Plus Therapeutics NASDAQ:PSTV$0.68 -0.15 (-17.74%) Closing price 04:00 PM EasternExtended Trading$0.69 +0.01 (+0.78%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus TherapeuticsMarket Capitalization$82.50 millionP/E Ratio-0.31Consensus RatingBuyConsensus Price Target$7.88 (+1,051.8% Upside)Volume47.65 million sharesAverage Volume35.40 million shares5. Quince Therapeutics NASDAQ:QNCX$1.63 +0.02 (+1.24%) Closing price 04:00 PM EasternExtended Trading$1.64 +0.01 (+0.86%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$86.48 millionP/E Ratio-1.50Consensus RatingBuyConsensus Price Target$8.14 (+399.6% Upside)Volume246,290 sharesAverage Volume193,216 shares6. Ovid Therapeutics NASDAQ:OVID$1.30 -0.10 (-7.14%) Closing price 04:00 PM EasternExtended Trading$1.36 +0.06 (+4.92%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$99.55 millionP/E Ratio-2.45Consensus RatingBuyConsensus Price Target$3.10 (+138.5% Upside)Volume3.01 million sharesAverage Volume1.92 million shares7. Context Therapeutics NASDAQ:CNTX$0.97 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$0.98 +0.01 (+0.64%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$86.90 millionP/E Ratio-2.69Consensus RatingBuyConsensus Price Target$5.20 (+436.7% Upside)Volume111,747 sharesAverage Volume164,721 shares8. Aclaris Therapeutics NASDAQ:ACRS$1.90 -0.02 (-1.04%) Closing price 04:00 PM EasternExtended Trading$1.90 0.00 (-0.26%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$208 millionP/E Ratio-1.39Consensus RatingBuyConsensus Price Target$8.71 (+358.6% Upside)Volume2.14 million sharesAverage Volume1.03 million shares9. Lucid Diagnostics NASDAQ:LUCD$1.01 -0.02 (-1.94%) Closing price 04:00 PM EasternExtended Trading$1.02 +0.01 (+1.49%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$137.48 millionP/E Ratio-0.85Consensus RatingBuyConsensus Price Target$3.65 (+261.4% Upside)Volume786,590 sharesAverage Volume1.60 million shares10. Werewolf Therapeutics NASDAQ:HOWL$1.97 -0.22 (-10.05%) Closing price 04:00 PM EasternExtended Trading$1.99 +0.02 (+1.22%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Werewolf Therapeutics, Inc, a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. More about Werewolf TherapeuticsMarket Capitalization$100.15 millionP/E Ratio-1.20Consensus RatingBuyConsensus Price Target$8.00 (+306.1% Upside)Volume1.76 million sharesAverage Volume752,191 shares11. Ur Energy NYSEAMERICAN:URG$1.79 +0.03 (+1.70%) Closing price 04:10 PM EasternExtended Trading$1.76 -0.03 (-1.62%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$646.33 millionP/E Ratio-10.53Consensus RatingBuyConsensus Price Target$2.44 (+36.3% Upside)Volume15.49 million sharesAverage Volume9.36 million shares12. Immunic NASDAQ:IMUX$0.88 -0.05 (-5.69%) Closing price 04:00 PM EasternExtended Trading$0.89 +0.01 (+1.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$92.22 millionP/E Ratio-0.94Consensus RatingBuyConsensus Price Target$9.50 (+977.6% Upside)Volume1.67 million sharesAverage Volume1.51 million shares13. Tenaya Therapeutics NASDAQ:TNYA$1.62 +0.04 (+2.53%) Closing price 04:00 PM EasternExtended Trading$1.62 +0.00 (+0.31%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$257.50 millionP/E Ratio-1.69Consensus RatingBuyConsensus Price Target$6.25 (+285.8% Upside)Volume3.73 million sharesAverage Volume3.40 million shares14. TScan Therapeutics NASDAQ:TCRX$1.82 +0.08 (+4.60%) Closing price 04:00 PM EasternExtended Trading$1.81 -0.01 (-0.77%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TScan Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. More about TScan TherapeuticsMarket Capitalization$98.74 millionP/E Ratio-1.67Consensus RatingBuyConsensus Price Target$7.80 (+328.6% Upside)Volume402,229 sharesAverage Volume254,623 shares15. Autolus Therapeutics NASDAQ:AUTL$1.63 +0.04 (+2.52%) Closing price 04:00 PM EasternExtended Trading$1.68 +0.05 (+3.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$423.17 millionP/E Ratio-1.94Consensus RatingBuyConsensus Price Target$9.12 (+459.5% Upside)Volume3.07 million sharesAverage Volume5.64 million shares16. InflaRx NASDAQ:IFRX$1.34 -0.03 (-2.19%) Closing price 04:00 PM EasternExtended Trading$1.38 +0.04 (+2.69%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRxMarket Capitalization$91.97 millionP/E Ratio-1.67Consensus RatingBuyConsensus Price Target$6.20 (+362.7% Upside)Volume171,111 sharesAverage Volume750,263 shares17. Gain Therapeutics NASDAQ:GANX$1.77 -0.04 (-2.21%) Closing price 04:00 PM EasternExtended Trading$1.74 -0.03 (-1.64%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$65.07 millionP/E Ratio-2.81Consensus RatingBuyConsensus Price Target$8.00 (+352.0% Upside)Volume924,197 sharesAverage Volume661,841 shares18. Reviva Pharmaceuticals NASDAQ:RVPH$0.37 +0.06 (+19.56%) Closing price 04:00 PM EasternExtended Trading$0.38 +0.02 (+4.18%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$21.38 millionP/E Ratio-0.57Consensus RatingBuyConsensus Price Target$4.86 (+1,217.7% Upside)Volume26.30 million sharesAverage Volume5.43 million shares19. Acrivon Therapeutics NASDAQ:ACRV$1.81 -0.01 (-0.55%) Closing price 04:00 PM EasternExtended Trading$1.76 -0.05 (-2.49%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Acrivon Therapeutics, Inc, a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. More about Acrivon TherapeuticsMarket Capitalization$57.25 millionP/E Ratio-0.80Consensus RatingBuyConsensus Price Target$15.00 (+728.7% Upside)Volume539,317 sharesAverage Volume3.60 million shares20. IceCure Medical NASDAQ:ICCM$1.01 -0.01 (-0.49%) Closing price 03:59 PM EasternExtended Trading$1.01 0.00 (-0.49%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. More about IceCure MedicalMarket Capitalization$70.07 millionP/E Ratio-6.34Consensus RatingBuyConsensus Price Target$2.39 (+135.0% Upside)Volume397,027 sharesAverage Volume1.13 million shares21. Humacyte NASDAQ:HUMA$1.74 +0.01 (+0.58%) Closing price 04:00 PM EasternExtended Trading$1.75 +0.01 (+0.57%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. More about HumacyteMarket Capitalization$273.98 millionP/E Ratio-3.87Consensus RatingModerate BuyConsensus Price Target$9.29 (+433.7% Upside)Volume2.28 million sharesAverage Volume3.18 million shares22. i-80 Gold NYSE:IAUX$0.96 -0.03 (-3.01%) Closing price 04:00 PM EasternExtended Trading$0.98 +0.02 (+2.05%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.i-80 Gold Corp. is a mining company, engages in the exploration, development and production of gold and silver mineral deposits principally in the United States. More about i-80 GoldMarket Capitalization$754.58 millionP/E Ratio-2.65Consensus RatingModerate BuyConsensus Price Target$1.50 (+57.0% Upside)Volume2.93 million sharesAverage Volume6.01 million shares23. ALX Oncology NASDAQ:ALXO$1.83 +0.08 (+4.57%) Closing price 04:00 PM EasternExtended Trading$1.86 +0.02 (+1.37%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. More about ALX OncologyMarket Capitalization$93.71 millionP/E Ratio-0.83Consensus RatingModerate BuyConsensus Price Target$3.30 (+80.3% Upside)Volume212,426 sharesAverage Volume708,181 shares24. Waldencast NASDAQ:WALD$1.98 -0.02 (-1.00%) Closing price 04:00 PM EasternExtended Trading$1.98 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. More about WaldencastMarket Capitalization$244.15 millionConsensus RatingModerate BuyConsensus Price Target$4.97 (+151.1% Upside)Volume202,528 sharesAverage Volume159,335 sharesToday's Range$1.92▼$2.0325. Oncolytics Biotech NASDAQ:ONCY$1.40 -0.01 (-0.71%) Closing price 04:00 PM EasternExtended Trading$1.39 -0.01 (-0.79%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. More about Oncolytics BiotechMarket Capitalization$141.51 millionP/E Ratio-5.18Consensus RatingModerate BuyConsensus Price Target$5.00 (+257.1% Upside)Volume1.16 million sharesAverage Volume1.49 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Draganfly's Army Partnership a Game-Changer for Investors? 154% Jump in Bullish Bets: Is Ford About to Hit the Gas? AppLovin Stock Momentum Builds With $800+ Analyst Price Target Why Vertical Aerospace Could Lead the eVTOL Market by 2028 Apple Stock Positioned for Holiday Gains With iPhone 17 Boost 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? This ETF Weeds Out Small-Cap Underperformers Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
